SUMO1 Promotes Mesangial Cell Proliferation Through Inhibiting Autophagy in a Cell Model of IgA Nephropathy.
Tan X, Liu Y, Liu D, Tang X, Xia M, Chen G, He L, Zhu X, Liu H.
Front Med (Lausanne). 2022 Mar 31;9:834164. doi: 10.3389/fmed.2022.834164. eCollection 2022.
PMID:35433764
Tenascin-C promotes the proliferation and fibrosis of mesangial cells in diabetic nephropathy through the beta-catenin pathway.
Pang X, Hou X, Hu C, Lu S, Gan H, Yang H, Xiang S, Zhou J, Gao H, Chen S.
Int Urol Nephrol. 2023 Oct;55(10):2507-2516. doi: 10.1007/s11255-023-03547-8. Epub 2023 Mar 24.
PMID:36964321
Ntrk1 promotes mesangial cell proliferation and inflammation in rat glomerulonephritis model by activating the STAT3 and p38/ERK MAPK signaling pathways.
Dong X, Tang Y.
BMC Nephrol. 2022 Dec 28;23(1):413. doi: 10.1186/s12882-022-03001-4.
PMID:36575400
Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo.
Floege J, Eng E, Young BA, Johnson RJ.
Kidney Int Suppl. 1993 Jan;39:S47-54.
PMID:8468926
Tetrandrine inhibits the proliferation of mesangial cells induced by enzymatically deglycosylated human IgA1 via IgA receptor/MAPK/NF-kappaB signaling pathway.
Xu W, Song W, Chen S, Jin S, Xue X, Min J, Wang X, You P.
Front Pharmacol. 2023 Jun 15;14:1150829. doi: 10.3389/fphar.2023.1150829. eCollection 2023.